Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

No reported Selling, General & Admin figures are available to summarize.

Selling, General & Admin history

Currency unavailable · from the income statement

No Selling, General & Admin data reported for this period type.

Selling, General & Admin vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Selling, General & Admin for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYTKCytokinetics, IncorporatedLTM Jun 2026$370.47M USD+53.0%+16.9%522.1%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$102.22M USD+6.5%+76.0%1435.5%
RNAAtrium Therapeutics, Inc.FY2025$41.68M USD——223.8%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$25.68M USD+75.9%+56.0%—
TNYATenaya Therapeutics, Inc.LTM Mar 2026$23.71M USD-4.5%+3.4%10537.3%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —+29.8%+36.4%978.8%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.